Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 15 studies | 34% ± 15% | |
astrocyte | 15 studies | 43% ± 15% | |
oligodendrocyte precursor cell | 12 studies | 47% ± 21% | |
oligodendrocyte | 12 studies | 42% ± 17% | |
glutamatergic neuron | 11 studies | 46% ± 26% | |
microglial cell | 11 studies | 40% ± 15% | |
GABAergic neuron | 8 studies | 46% ± 22% | |
macrophage | 8 studies | 38% ± 20% | |
fibroblast | 8 studies | 30% ± 12% | |
mast cell | 7 studies | 32% ± 8% | |
interneuron | 6 studies | 47% ± 19% | |
adipocyte | 6 studies | 24% ± 6% | |
smooth muscle cell | 6 studies | 24% ± 6% | |
neuron | 5 studies | 52% ± 24% | |
epithelial cell | 5 studies | 30% ± 18% | |
endothelial cell of lymphatic vessel | 5 studies | 36% ± 8% | |
monocyte | 5 studies | 29% ± 7% | |
pericyte | 4 studies | 37% ± 15% | |
cardiac muscle cell | 4 studies | 39% ± 3% | |
dendritic cell | 4 studies | 21% ± 2% | |
Mueller cell | 4 studies | 25% ± 8% | |
myeloid cell | 4 studies | 27% ± 9% | |
type II pneumocyte | 4 studies | 25% ± 8% | |
GABAergic interneuron | 3 studies | 33% ± 13% | |
granule cell | 3 studies | 30% ± 11% | |
CD4-positive, alpha-beta T cell | 3 studies | 26% ± 1% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
hepatocyte | 3 studies | 42% ± 26% | |
ependymal cell | 3 studies | 45% ± 15% | |
T cell | 3 studies | 21% ± 5% | |
ciliated cell | 3 studies | 27% ± 8% | |
natural killer cell | 3 studies | 25% ± 3% | |
type I pneumocyte | 3 studies | 22% ± 4% | |
lymphocyte | 3 studies | 38% ± 10% | |
basal cell | 3 studies | 36% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4511.24 | 1445 / 1445 | 100% | 10.66 | 183 / 183 |
brain | 99% | 2075.72 | 2604 / 2642 | 100% | 18.68 | 704 / 705 |
prostate | 100% | 2668.45 | 244 / 245 | 98% | 5.94 | 492 / 502 |
intestine | 100% | 7696.84 | 966 / 966 | 97% | 6.06 | 512 / 527 |
skin | 99% | 2011.37 | 1786 / 1809 | 97% | 9.19 | 459 / 472 |
lung | 99% | 1829.17 | 572 / 578 | 94% | 5.99 | 1083 / 1155 |
ovary | 100% | 2417.01 | 180 / 180 | 92% | 5.90 | 397 / 430 |
adrenal gland | 100% | 2715.11 | 258 / 258 | 91% | 6.50 | 209 / 230 |
uterus | 100% | 3660.20 | 170 / 170 | 90% | 5.61 | 414 / 459 |
stomach | 93% | 2704.16 | 333 / 359 | 97% | 7.04 | 277 / 286 |
breast | 100% | 1747.27 | 457 / 459 | 89% | 4.56 | 997 / 1118 |
thymus | 100% | 1923.45 | 651 / 653 | 88% | 6.26 | 532 / 605 |
bladder | 100% | 4299.24 | 21 / 21 | 71% | 3.44 | 356 / 504 |
pancreas | 76% | 751.32 | 248 / 328 | 94% | 4.68 | 168 / 178 |
kidney | 91% | 1135.46 | 81 / 89 | 77% | 3.17 | 696 / 901 |
muscle | 100% | 12081.40 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2600.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 6.31 | 45 / 45 |
adipose | 99% | 1723.84 | 1197 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1705.59 | 1320 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 22.68 | 79 / 80 |
heart | 93% | 1228.04 | 800 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 2837.02 | 848 / 929 | 0% | 0 | 0 / 0 |
liver | 42% | 351.27 | 95 / 226 | 42% | 1.62 | 171 / 406 |
lymph node | 0% | 0 | 0 / 0 | 72% | 2.94 | 21 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0016925 | Biological process | protein sumoylation |
GO_0006954 | Biological process | inflammatory response |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0014898 | Biological process | cardiac muscle hypertrophy in response to stress |
GO_0014894 | Biological process | response to denervation involved in regulation of muscle adaptation |
GO_0006476 | Biological process | protein deacetylation |
GO_0010944 | Biological process | negative regulation of transcription by competitive promoter binding |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0006338 | Biological process | chromatin remodeling |
GO_0043393 | Biological process | regulation of protein binding |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_0010832 | Biological process | negative regulation of myotube differentiation |
GO_0060337 | Biological process | type I interferon-mediated signaling pathway |
GO_0033235 | Biological process | positive regulation of protein sumoylation |
GO_0034983 | Biological process | peptidyl-lysine deacetylation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0042113 | Biological process | B cell activation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0007399 | Biological process | nervous system development |
GO_0030183 | Biological process | B cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0033558 | Molecular function | protein lysine deacetylase activity |
GO_0019789 | Molecular function | SUMO transferase activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0042393 | Molecular function | histone binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0004407 | Molecular function | histone deacetylase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0030955 | Molecular function | potassium ion binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | HDAC4 |
Protein name | Histone deacetylase 4 (HD4) (EC 3.5.1.98) Histone deacetylase (EC 3.5.1.98) histone deacetylase (EC 3.5.1.98) Histone deacetylase 4 |
Synonyms | KIAA0288 |
Description | FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. . FUNCTION: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation via its interaction with the myocyte enhancer factors such as MEF2A, MEF2C and MEF2D. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. Deacetylates HSPA1A and HSPA1B at 'Lys-77' leading to their preferential binding to co-chaperone STUB1 . . |
Accessions | ENST00000543185.6 ENST00000446876.1 ENST00000454542.5 P56524 A0A7I2SVS4 ENST00000445704.1 C9J0X4 H7C397 ENST00000430200.1 C9J481 H7BZT3 ENST00000345617.7 [P56524-1] |